Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
European Urology|July 16, 2013
Enzalutamide in castration-resistant prostate cancer patients progressing after docetaxel and abirateroneAndres Jan Schrader, Martin Boegemann, Carsten-H Ohlmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2020
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysisRobert Seifert, Katharina Kessel, Katrin Schlack, et al.
European Urology|August 11, 2014
Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre AnalysisKlaus Brasso, Frederik B Thomsen, Andres J Schrader, et al.
Scientific Reports|March 4, 2024
Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathologyOkyaz Eminaga, Mahmoud Abbas, Christian Kunder, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE dataNeal Shore, Alicia K Morgans, Noman Paracha, et al.
Future Oncology (London, England)|September 23, 2020
Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinomaPeter J Goebell, Philipp Ivanyi, Jens Bedke, et al.
Aktuelle Urologie|November 21, 2019
[Knowledge of German-speaking urologists regarding the association between penile cancer and human papilloma virus: results of a survey of the European PROspective Penile Cancer Study (E-PROPS)]Steffen Lebentrau, Ingmar Wolff, Marie Christine Hempel, et al.
BMC Cancer|January 16, 2019
Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort studyMartin Boegemann, Sara Khaksar, Guillaume Bera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2023
Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate CancerAurelius Omlin, Richard Cathomas, Gunhild von Amsberg, et al.
BMC Cancer|July 2, 2025
Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancerMartin Boegemann, Mostefa Bennamoun, Louis Marie Dourthe, et al.
Pageof 6